Epidural Analgesia and Intraoperative Fluid Management in Colorectal Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

121 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-01

Study Completion Date

2020-10-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Enhanced Recovery After Surgery (ERAS) protocols have demonstrated their efficacy in expediting recovery and minimizing postoperative complications, especially in patients undergoing abdominal surgery. Perioperative hydration is one of the most critical pillars of the ERAS protocols, with goal-directed methods for administering fluids increasingly incorporated into these protocols.

The Goal-Directed Fluid Therapy (GDFT) method is a strategy used in perioperative and critical care settings to optimize fluid administration tailored to a patient's individual needs. Its goal is to maintain adequate tissue perfusion and oxygenation by precisely balancing fluid administration, avoiding both hypovolemia (too little fluid) and fluid overload. Rather than using a "one-size-fits-all" approach, GDFT adjusts fluid delivery based on real-time monitoring of the patient's physiological parameters. GDFT focuses on dynamic hemodynamic indicators, such as stroke volume (SV), stroke volume variation (SVV), and cardiac output (CO), which provide better insight into the patient's fluid responsiveness. Advanced monitoring tools, such as esophageal Doppler, pulse contour analysis, or invasive devices like a pulmonary artery catheter, are used to assess the patient's response to fluid administration. The implementation of such protocols, particularly in colorectal surgery, has proven beneficial, as both overhydration and underhydration in this context can significantly impair organ function and, consequently, affect patient outcomes. Hypovolemia may lead to tissue ischemia at the anastomotic site, potentially causing breakdown. Conversely, fluid overload can have harmful consequences; hyperhydration may cause tissue edema, thereby reducing anastomotic strength. However, these findings have been validated primarily in high-risk patients, with a limited number of studies involving low- to moderate-risk patients undergoing major abdominal surgery.

Colorectal surgery is routinely managed with epidural analgesia combined with general anaesthesia. However, concerns have been raised that epidurally induced sympathetic blockade and vasoplegia (vasodilation) can cause haemodynamic instability, necessitating fluid and vasopressor administration to an uncertain extent.

In this single-center trial, we aimed to investigate whether epidural analgesia, in addition to general anaesthesia, influences Stroke Volume Variation (SVV)-guided GDFT using the FloTrac/Vigileo monitor during major open abdominal surgery. The study hypothesis was that epidural analgesia may result in fluid overload to compensate for the induced vasoplegia and that this fluid overload, in turn, could lead to gastrointestinal dysfunction and prolong the length of hospital stay.

The primary outcomes were the incidence of postoperative gastrointestinal dysfunction and the length of hospital stay following elective colorectal surgery in patients managed with GDFT, either with or without epidural analgesia. Additionally, patient records of those treated with conventional fluid therapy (CFT), with or without epidural analgesia, were reviewed retrospectively for comparison.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Goal-directed Intraoperative Fluid Therapy in High-risk Surgery

NCT02470221

Postoperative Complications Fluid Overload

COMPLETED

Fluid Optimisation in Laparoscopic Colorectal Procedures

NCT04719884

Perioperative Complication

COMPLETED NA

Implementation of Computer-Assisted Intraoperative Goal-Directed Fluid Therapy

NCT02978430

Major Abdominal Surgery

COMPLETED PHASE2

The Effect of Intraoperative Goal Directed Restricted Fluid Therapy on Extravascular Lung Water

NCT02845310

Surgery

COMPLETED NA

Restrictive Versus Conservative Fluid Therapy in Colorectal Surgery

NCT03070080

Fluid Therapy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Existing evidence regarding the implementation of Enhanced Recovery After Surgery (ERAS) protocols highlights their benefits in accelerating the recovery process and reducing hospital stay durations. Additionally, postoperative morbidity, mortality, and rehospitalization rates are lower in patients following these protocols. A key component of ERAS protocols is perioperative fluid management, which is critical for gastrointestinal recovery after major abdominal surgery. Both overhydration and underhydration can significantly impair organ function and, consequently, affect patient outcomes.

Goal-directed fluid therapy (GDFT), utilizing dynamic volume measurements, enables balanced fluid administration. Numerous studies support the implementation of such protocols, particularly in major abdominal surgeries. Colonic anastomotic leakage is one of the most serious complications following colorectal surgery, with a reported incidence of up to 20%. Anastomotic breakdown is associated with increased morbidity and mortality, resulting in prolonged hospitalization, depletion of healthcare resources, and elevated costs. Hypovolemia can lead to tissue ischemia at the anastomotic site, causing breakdown. Conversely, fluid overload may have harmful consequences; hyperhydration can lead to tissue edema, thereby reducing anastomotic strength. These findings underscore the importance of maintaining euvolemia during colorectal surgeries, supporting the inclusion of GDFT as an essential component of the anesthetic protocol. However, the benefits of GDFT in abdominal surgery have been predominantly investigated and validated in high-risk patients. Only a limited number of studies involve low- to moderate-risk patients undergoing major abdominal surgery.

Epidural analgesia, combined with general anaesthesia, is considered the gold standard anaesthetic regimen for major abdominal surgery. However, the resulting sympathetic blockade and vasoplegia can cause haemodynamic instability, affecting fluid administration and vasopressor requirements to an uncertain extent. Various clinical and laboratory markers have been employed to monitor the effects of perioperative fluid management. Evidence suggests that B-type Natriuretic Peptide (BNP) levels are associated with fluid balance, morbidity and mortality at 30 days or even 180 days after non-cardiac surgery, and length of hospital stay. However, the concept of using risk predictors such as BNP in surgeries involving significant fluid loss and redistribution, such as colorectal surgeries, remains insufficiently studied.

This single-center trial was conducted to investigate whether epidural analgesia, in addition to general anaesthesia, influences Stroke Volume Variation (SVV) guided GDFT using the FloTrac/Vigileo monitor in major open abdominal surgery. The study hypothesis was that epidural analgesia may result in overhydration to compensate for the induced vasoplegia, thereby affecting gastrointestinal function and length of hospital stay. The primary outcome was the effect of epidural analgesia on the incidence of postoperative gastrointestinal dysfunction and the length of hospital stay in low- to moderate-risk patients undergoing open major abdominal surgery managed with intraoperative GDFT. Secondary outcomes included the total volume of fluids administered, assessment of proBNP levels as a marker of fluid balance, incidence of postoperative adverse events, and all-cause in-hospital mortality. Additionally, patients' records treated with conventional fluid therapy (CFT) with or without epidural analgesia were reviewed retrospectively for comparison.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ERAS Colorectal Surgery Goal-directed Fluid Therapy Conventional Fluid Therapy Epidural Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients were randomly allocated into four groups based on different anesthetic modalities for intraoperative fluid management and analgesic strategy: The GDFT group received goal-directed fluid therapy and continuous intravenous analgesia, the GDFT/ED group received goal-directed fluid therapy and epidural analgesia, the CFT group received conventional fluid administration and continuous intravenous analgesia, and the CFT/ED group received conventional fluid administration and epidural analgesia. Data for the GDFT and GDFT/ED groups were collected prospectively, while data for the CFT and CFT/ED groups were collected retrospectively

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GDFT group

Patients in the GDFT group were managed perioperatively using goal-directed fluid administration and continuous intravenous analgesia.

Group Type EXPERIMENTAL

GDFT

Intervention Type PROCEDURE

Hydration was goal-directed and guided by Stroke Volume Variation (SVV) using the FloTrac/Vigileo monitor, while analgesia was provided with intravenous analgesics.

GDFT/ED group

Patients in the GDFT/ED group were managed perioperatively using goal-directed fluid administration and epidural analgesia.

Group Type EXPERIMENTAL

GDFT/ED

Intervention Type PROCEDURE

Hydration was goal-directed and guided by Stroke Volume Variation (SVV) using the FloTrac/Vigileo monitor, while analgesia was administered via epidural analgesics.

CFT

Patients in the CFT group were managed perioperatively using conventional fluid administration and continuous intravenous analgesia.

Group Type EXPERIMENTAL

CFT

Intervention Type PROCEDURE

Patients received conventional fluid therapy (based on heart rate, urine output and mean arterial pressure) and analgesia was provided with intravenous analgesics.

CFT/ED

Patients in the CFT group were managed perioperatively using conventional fluid administration and epidural analgesia.

Group Type EXPERIMENTAL

CFT/ED

Intervention Type PROCEDURE

Patients received conventional fluid therapy (based on heart rate, urine output and mean arterial pressure) and analgesia was administered via epidural analgesics.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GDFT

Hydration was goal-directed and guided by Stroke Volume Variation (SVV) using the FloTrac/Vigileo monitor, while analgesia was provided with intravenous analgesics.

Intervention Type PROCEDURE

GDFT/ED

Hydration was goal-directed and guided by Stroke Volume Variation (SVV) using the FloTrac/Vigileo monitor, while analgesia was administered via epidural analgesics.

Intervention Type PROCEDURE

CFT

Patients received conventional fluid therapy (based on heart rate, urine output and mean arterial pressure) and analgesia was provided with intravenous analgesics.

Intervention Type PROCEDURE

CFT/ED

Patients received conventional fluid therapy (based on heart rate, urine output and mean arterial pressure) and analgesia was administered via epidural analgesics.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Prospective group Prospective group Retrospective group Retrospective group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults
* elective oncological colorectal surgery
* ASA (American Society of Anesthesiologists physical status classification) I \& II

Exclusion Criteria

* extremes of weight (\< 55 kg or \> 120 kg)
* known history of arrhythmias
* recent unstable coronary syndrome
* decompensated heart failure
* severe aortic valve stenosis
* impaired renal function (serum creatinine level \> 2.0 mg/dL)
* inability to communicate
* refusal to provide consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No